Citius (CTXR) Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PHASE III PROGRESS
October 7th, 2019, Citius Completes 40% - Triggers Data Being Analyzed (is it working?).December 19th, 2019...
Okay, so What’s Next for Citius Pharma (CTXR) $1.16?
Dawson James Broker/Dealer Updates. Price Target Remains at $7.00.
"OK, So what’s Next? Topline data from the superior efficacy...
Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.
STREET INSIDER
H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).
Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...
Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce Vaccines to Battle...
Dyadic (DYAI) has developed a biomanufacturing technology platform, nicknamed C1 which helps to speed the development, lower the manufacturing cost and potentially...
Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.
Our First Newsletter of 2020, We Come out Swinging!
Yes, you read it right. Five of our favorite...
New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.
Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the...
Citius Pharma (CTXR) Corporate Presentation (Jan 2020).
In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic...
Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.
True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors.
True Nature|Mitesco President & COO, Julie Smith Interview.
Julie R. Smith is a seasoned senior executive...
Latest article
Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!
This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36.
We last added Bavarian to...
Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)
Sorting Through the Wreckage!
Full post on Investor's Business Daily.
Biotech stocks took a beating Monday...
Zomedica (ZOMDF) Surges 40% Higher, Friday.
Stock Surges 40%, After Management Conference Call to Calm the Natives.
Insider Buying Unleashed Today?
Not...
